On the whole, there is no benefit to adding docetaxel at the end of radiation and then continuing with long-term ADT in high risk men. One trial (GETUG-12) found a benefit to chemo PRE-treatment.
Another randomized clinical trial sho... - Prostate Cancer N...
Another randomized clinical trial shows no benefit to adding docetaxel to radiation + ADT in high risk patients
Written by
Tall_Allen
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Adding ADT to external beam radiation only benefits unfavorable risk patients
"Favorable intermediate risk" patients are sometimes overtreated by doctors who give them adjuvant...
No difference in SBRT vs conventionally fractionated radiation for intermediate risk patients
6-year update of PACE-B randomized trial continues to show no difference in outcomes. This month is...
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer
This just appeared in today's email. Apparently a database study of patients treated 2010-2016. At...
Long-term adjuvant ADT improves results of brachy boost therapy in unfavorable-risk prostate cancer patients
For most unfavorable risk prostate cancer patients, brachy boost therapy is the preferred option....
Early side effects of docetaxel
Hi All,
I'm writing for some advice regarding the early side effects of docetaxel. Mt partner...
Related Posts
- FDA approves Erleada for metastatic hormone-sensitive prostate cancer
Short-term vs Long-Term ADT for High Risk Men 
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies
ANY SUGGESTIONS?
What is the role of androgen deprivation and prostate cancer treatment?
